Dow Jones Top Company Headlines at 11 AM ET: Cal-Maine Foods to Cull 1.76 Million Birds After Florida Facility Tests Positive for Bird Flu | Target ...
Cal-Maine Foods to Cull 1.76 Million Birds After Florida Facility Tests Positive for Bird Flu
The birds include roughly 1.4 million laying hens and 360,000 pullets, representing about 2.7% of the company's total flock, the egg producer said.
----
Target Posts Strongest Sales Growth in Years
Target posted its strongest quarterly sales growth in about five years as it introduced new products and lowered prices on some items, both key focuses of its turnaround strategy.
----
Lowe's Lifts Outlook Following Higher Sales
The home-improvement retailer on posted a fiscal third-quarter profit of $1.67 billion, or $2.98 a share, compared with $1.62 billion, or $2.88 a share, a year earlier.
----
TJX Raises Full-Year Outlook, Expects Sales Trends to Accelerate Through Holiday Season
TJX bumped up its full-year outlook again as it expects strong demand for its portfolio of off-price stores over the key holiday shopping period.
----
Nvidia's Strong Fundamentals Give New CEO a Much-Needed Tailwind
The company inherits problems from Jensen Huang, and advantages.
----
Tencent Profit Flatlines Amid Surging AI Investments, Revenue Growth Slows
The Chinese technology titan's capital expenditure jumped more than sixfold from a year earlier, eroding its profit growth in the third quarter.
----
Textron Selling Industrial Segment to Kingswood Capital for $1.2 Billion
The signed a definitive sale agreement with an affiliate of Kingswood Capital Management that will see it bring in net cash proceeds of roughly $1.1 billion after tax and transaction-related expenses.
----
Alstom Shares Drop After Train Maker Floats Possible Equity Raise
Shares fell more than 7% after the French train maker said it was considering equity funding and asset sales, among other options, to cut its debt load.
----
Alphabet's Waymo Pulls Robotaxis Off Freeways After California Ban
Waymo has temporarily restricted freeway operations in the U.S., following a California ban after a few incidents involving its robotaxis.
----
Anthropic Plans to Raise IPO Price After Strong Demand
The company has pitched investors through market tumult and the shock resignation of Nvidia's Jensen Huang.
----
GSK Gets FDA Approval for New Lung-Cancer Drug
GSK can now launch a new medicine in the U.S. for lung cancer, a move that bolsters its efforts to build a franchise in a disease that is the leading cause of cancer death.
----
Mary Barra Transformed GM. Her Successor May Have to Do It Again.
Under Barra, GM has become leaner and more profitable-but the next CEO faces high-tech challenges in China and beyond.
----
Nvidia's Interim CEO Has a Tough Challenge: Keep the Growth, Leave the Baggage
Colette Kress signaled accelerating demand and cautious backstopping, but the chip giant still faces questions regarding past deals and succession.
(END) Dow Jones Newswires
November 18, 2026 11:15 ET (16:15 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

5 Stocks to Buy After Earnings

7 Undervalued Stocks That Crushed Earnings

This Newly Undervalued Stock Has Plenty of Growth Ahead

Are These Riskier Bond ETFs Worth the Higher Yields?

